Losing weight is not always as simple as eating less and exercising more. Appetite regulation, genetics, medications, sleep, metabolic health, medical conditions, and environmental factors can all affect a person’s ability to lose weight and maintain the results.
For eligible patients, prescription weight loss injections may provide additional support. These medications work with hormone pathways involved in appetite, fullness, digestion, and blood sugar regulation.
However, weight loss injections are not quick cosmetic treatments or substitutes for healthy habits. They are prescription medications that require appropriate patient selection, realistic expectations, medical supervision, and ongoing follow-up.
At ProMD Health Lewes, the medical weight loss program combines personalized treatment with nutrition, physical activity, lifestyle guidance, and progress monitoring.
Here are seven essential facts to understand before beginning weight loss injections.
1. Weight Loss Injections Affect Appetite and Fullness
Many modern weight management medications act on hormone receptors involved in appetite regulation.
Semaglutide is a glucagon-like peptide-1 receptor agonist, commonly called a GLP-1 receptor agonist. It imitates the activity of a naturally occurring hormone that helps regulate appetite and food intake.
Tirzepatide works on two hormone pathways. It activates both glucose-dependent insulinotropic polypeptide, or GIP, receptors and GLP-1 receptors.
These medications may help patients:
- Feel full after eating smaller portions
- Remain satisfied for longer
- Experience less persistent hunger
- Reduce certain food cravings
- Follow a structured nutrition plan more consistently
- Improve some markers of metabolic health
The medications also affect digestion and can slow the movement of food from the stomach. This is one reason gastrointestinal side effects may occur, particularly when treatment begins or the dose increases.
Weight loss still depends on several factors. The medication creates support, but it does not remove the need for appropriate nutrition, physical activity, sleep, and long-term behavioral changes.
2. Semaglutide and Tirzepatide Are Not Identical
Semaglutide and tirzepatide are sometimes discussed as though they are interchangeable. Although they have similarities, they are different medications.
Semaglutide
Semaglutide activates GLP-1 receptors. Wegovy is an FDA-approved semaglutide medication used for chronic weight management in eligible patients.
Semaglutide is also the active ingredient in other prescription medications intended for different medical indications. Products containing the same active ingredient should not be assumed to have the same approved purpose, dose, or treatment instructions.
Tirzepatide
Tirzepatide activates both GIP and GLP-1 receptors. Zepbound is an FDA-approved tirzepatide medication used for chronic weight management in eligible patients.
Tirzepatide is also found in Mounjaro, which has a different FDA-approved indication. The brand prescribed, the patient’s diagnosis, and the intended use all matter.
Your provider should explain:
- Which medication is being recommended
- Why it may be appropriate for you
- Whether the product is FDA-approved for the intended use
- How it should be administered
- What risks and side effects should be considered
- How your progress will be monitored
Never assume that a medication is appropriate simply because it has been promoted online or used successfully by someone else.
3. Not Everyone Is a Candidate
Prescription weight loss medications are intended for patients who meet specific medical criteria.
FDA-approved weight management medications may generally be considered for adults with obesity or for certain adults with overweight who also have at least one weight-related medical condition. Eligibility must be determined by a qualified healthcare provider.
Your consultation may include a review of:
- Your current weight and body mass index
- Previous weight loss attempts
- Blood pressure
- Blood sugar history
- Cholesterol levels
- Current medications
- Digestive health
- Kidney, liver, gallbladder, and pancreatic history
- Personal and family medical history
- Pregnancy status or plans
- Eating patterns and physical activity
- Your ability to attend follow-up appointments
Semaglutide and tirzepatide products carry boxed warnings concerning the risk of thyroid C-cell tumors observed in animal studies. These medications should not be used by patients with a personal or family history of medullary thyroid carcinoma or by patients with multiple endocrine neoplasia syndrome type 2.
Weight loss medications are also not appropriate during pregnancy. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss this with their healthcare provider.
Be honest about your complete medical history. Information that may seem unrelated can affect whether a particular treatment is safe or appropriate.
4. Treatment Usually Begins Gradually
Weight loss injections are generally not started at the full maintenance dose.
Treatment commonly begins at a lower dose, followed by gradual increases according to the medication’s prescribing instructions and the patient’s response. This process is sometimes called dose escalation or titration.
Beginning gradually allows the provider to assess:
- How well the medication is tolerated
- Whether side effects are manageable
- How appetite and eating patterns change
- Whether the patient is following the treatment plan
- Whether another medical issue requires attention
Increasing the dose faster than prescribed does not guarantee faster or better weight loss. It may increase the likelihood of nausea, vomiting, diarrhea, constipation, dehydration, and other complications.
Patients should use the medication exactly as directed. Do not increase the dose, take additional injections, or combine weight management medications without approval from the prescribing provider.
Treatment schedules should be based on medical guidance rather than social media advice or another patient’s experience.
5. Side Effects and Risks Must Be Taken Seriously
The most commonly reported side effects of GLP-1 and related medications involve the digestive system.
These may include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal discomfort
- Indigestion
- Reduced appetite
Some side effects may improve as the body adjusts. Others may require a dosage change, additional evaluation, or discontinuation of treatment.
Patients should also understand the possibility of more serious complications. Depending on the medication, warnings and precautions may include:
- Pancreatitis
- Gallbladder disease
- Kidney injury related to dehydration
- Severe gastrointestinal reactions
- Allergic reactions
- Low blood sugar when combined with certain diabetes medications
- Changes in diabetic retinopathy
- Potential interactions with oral medications
Contact your provider if side effects are persistent, severe, or interfere with your ability to eat and drink normally.
Seek prompt medical attention for symptoms such as severe or continuing abdominal pain, repeated vomiting, signs of dehydration, difficulty breathing, swelling of the face or throat, or other concerning reactions.
Your provider should explain which symptoms are expected, which should be reported, and which require urgent medical care.
6. Healthy Habits Remain Part of Treatment
Weight loss injections are intended to accompany nutrition and physical activity changes. They do not make those habits unnecessary.
Because the medications may reduce appetite significantly, patients need to pay attention to the nutritional quality of the food they do consume. Eating substantially less without a thoughtful plan can make it difficult to obtain enough protein, vitamins, minerals, fiber, and total energy.
A comprehensive plan may address:
Protein intake
Adequate protein can help support muscle maintenance during weight loss. Your specific needs depend on your body size, activity level, health, and treatment plan.
Hydration
Nausea, vomiting, diarrhea, or reduced food intake can increase the risk of dehydration. Patients should follow their provider’s hydration recommendations and report difficulty keeping fluids down.
Fiber and digestion
A gradual increase in appropriate fiber and fluid intake may help some patients manage constipation. Sudden dietary changes can sometimes worsen digestive discomfort, so recommendations should be personalized.
Physical activity
Exercise supports cardiovascular health, mobility, mood, strength, and weight maintenance. Resistance training may be particularly helpful for preserving muscle during weight loss when medically appropriate.
Sleep and stress
Insufficient sleep and chronic stress may influence appetite, food choices, energy, and adherence to a weight management plan.
Long-term routines
The goal is not only to lose weight during treatment. Patients should develop routines they can realistically continue over time.
ProMD Health Lewes incorporates nutrition, activity, healthy lifestyle habits, and ongoing monitoring into its personalized weight management program.
7. Weight Maintenance Requires a Long-Term Plan
Many patients want to know how much weight they will lose and how quickly it will happen. No responsible provider can guarantee a specific result.
Outcomes vary according to:
- The medication prescribed
- The dose reached and tolerated
- Starting weight
- Medical history
- Nutrition and activity
- Treatment adherence
- Side effects
- Duration of treatment
- Individual biological response
Some patients notice appetite changes within the first several weeks. Changes in body weight generally develop progressively rather than immediately.
Weight management is also not finished when a target number appears on the scale. A long-term plan should address how results will be maintained.
Stopping treatment can allow appetite and hunger signals to increase again. Some patients may regain weight after discontinuing medication, particularly when sustainable routines and an appropriate maintenance strategy have not been established.
Before beginning treatment, ask your provider:
- How long might I remain on this medication?
- How will we measure progress?
- What happens if I reach a plateau?
- When would the dose be adjusted?
- What happens if side effects become difficult?
- What is the plan after I reach my goal?
- What costs should I expect over time?
These conversations help establish realistic expectations before treatment begins.
What to Expect From a Medically Supervised Program
A medically supervised program involves more than providing a prescription.
Your initial appointment should include a review of your medical history, current medications, previous weight loss attempts, lifestyle, and goals. The provider may recommend laboratory testing or request information from another healthcare professional when appropriate.
Once treatment begins, follow-up appointments allow the medical team to evaluate:
- Changes in weight and measurements
- Appetite and eating patterns
- Medication tolerance
- Side effects
- Hydration and nutrition
- Physical activity
- Changes in health conditions
- Whether the current dose remains appropriate
Ongoing monitoring also gives patients an opportunity to ask questions and address difficulties before they interfere with progress.
A provider may recommend changing the dose, delaying an increase, switching treatment, or stopping medication based on the patient’s response.
Why Medication Source Matters
Patients should know exactly what medication they are receiving and where it comes from.
FDA-approved medications have undergone regulatory review for specific uses, manufacturing standards, safety, and effectiveness. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality before they are marketed.
The FDA has raised concerns about unapproved GLP-1 products, including dosing errors, fraudulent labeling, inappropriate ingredients, and products marketed as research chemicals.
Before beginning treatment, ask:
- What is the exact medication name?
- Who manufactures it?
- Is it FDA-approved for weight management?
- Is it a compounded medication?
- Which pharmacy dispenses it?
- How should it be stored?
- Who should I contact with a medication problem?
Patients should avoid purchasing injectable medications through social media, unverified websites, or sellers that do not require a legitimate prescription and medical evaluation.
Schedule a Weight Loss Consultation in Lewes, DE
Weight loss injections may be helpful for eligible patients, but successful treatment requires more than choosing a medication. Appropriate screening, gradual dosing, medical monitoring, nutrition, physical activity, and a realistic maintenance plan all contribute to a safer and more sustainable approach.
ProMD Health Lewes provides personalized medical weight management at 1537 Savannah Road, Suite A, Lewes, Delaware 19958. The practice serves patients from Lewes, Rehoboth Beach, Milton, Milford, and nearby communities.
Book a medical weight loss consultation or call (302) 412-0135 to learn whether prescription weight loss injections may be appropriate for you.
Frequently Asked Questions
How do weight loss injections work?
Medications such as semaglutide and tirzepatide act on hormone receptors involved in appetite, fullness, digestion, and blood sugar regulation. They may help patients feel satisfied after eating smaller amounts and experience less persistent hunger.
How quickly will I lose weight?
Results vary. Some patients notice appetite changes during the first several weeks, while measurable weight loss develops progressively. The medication, dose, treatment duration, lifestyle, medical history, and individual response all influence results.
Are weight loss injections taken every week?
Many injectable semaglutide and tirzepatide treatment plans use once-weekly administration. The exact schedule depends on the prescribed product and the provider’s instructions. Patients should never change their injection schedule independently.
What are the most common side effects?
Common side effects include nausea, vomiting, diarrhea, constipation, abdominal discomfort, indigestion, and reduced appetite. Contact your provider if symptoms are severe, persistent, or prevent normal eating and hydration.
Can I take weight loss injections if I do not have diabetes?
Certain semaglutide and tirzepatide products are FDA-approved for chronic weight management in eligible patients who do not have diabetes. A medical provider must determine whether you meet the applicable criteria.
Will I regain weight after stopping treatment?
Some patients regain weight after discontinuing medication, especially when appetite returns and a long-term maintenance plan is not in place. Nutrition, physical activity, behavioral routines, continued monitoring, and an individualized maintenance strategy remain important.
Are compounded weight loss injections FDA-approved?
No. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before marketing. Patients should ask their provider whether the prescribed medication is FDA-approved or compounded and understand why a particular option is being recommended.